Third degree AV block echocardiography and ultrasound: Difference between revisions
No edit summary |
|||
(16 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Third degree AV block}} | {{Third degree AV block}} | ||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Sara.Zand}} {{Soroush}} | ||
==Overview== | ==Overview== | ||
[[Echocardiography]] is useful for evaluation of underlying [[structural heart disease]] in [[patients]] presented with [[bradycardia]] or [[conduction abnormality]]. Common indications for [[echocardiography]] in suspicion of [[cardiac origin]] of [[bradycardia]] or [[conduction disorder]] may include [[syncope]], [[lightheadedness]]/[[presyncope]], [[symptoms]] related to [[aortic stenosis]], [[hypertrophic cardiomyopathy]], [[heart failure]]. | |||
==[[Echocardiography]]== | |||
[[Echocardiography]] is useful for evaluation of underlying [[structural heart disease]] in [[patients]] presented with [[bradycardia]] or [[conduction abnormality]] including [[cardiomyopathy]], [[valvular heart disease]], [[congenital]] anomalies, [[tumors]], [[infections]], [[infiltrative processes]], [[immunologically]] mediated [[conditions]], and diseases of the [[great vessels]] and [[pericardium]]. | |||
* Common indications for [[echocardiography]] in suspicion of [[cardiac origin]] of [[bradycardia]] or [[conduction disorder]] may include: | |||
:* [[Syncope]] | |||
:* [[Lightheadedness]]/[[presyncope]] | |||
:* [[Symptoms]] related to [[aortic stenosis]], [[hypertrophic cardiomyopathy]], [[heart failure]] | |||
[[ | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align=center |'''Recommendations for Echocardiography in Bradycardia or Conduction disorder''' | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''[[Echocardiography]] ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]]):''' | |||
|- | |||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |||
❑ [[Echocardiography]] is recommended in [[patients]] with newly identified [[LBBB]], [[second-degree Mobitz type II atrioventricular block]], [[high-grade atrioventricular block]], or [[third-degree atrioventricular block]] with or without apparent [[structural heart disease]] or [[coronary artery disease]]<br> | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left|''' [[Echocardiography]] ([[ACC AHA guidelines classification scheme| Class IIa, Level of Evidence B]]) :''' | |||
|- | |||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |||
❑ [[Echocardiography]] is recommended in suspicion of [[structural heart disease]] in [[patients]] presented with [[bradycardia]] or [[conduction disorders]] other than [[LBBB]], [[second-degreeMobitz type II atrioventricular block]], [[high-grade atrioventricular block]], or [[third-degree atrioventricular block]] | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Advanced [[imaging]] : ([[ACC AHA guidelines classification scheme|Class IIa, Level of Evidence C]])''' | |||
|- | |||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |||
❑ In suspicion of [[structural heart disease]] in [[patients]] presented with [[bradycardia]] or [[bundle branch block]], [[transesophageal echocardiography]], [[computed tomography]], [[cardiac magnetic resonance imaging]] ([[MRI]]),or [[nuclear imaging]] is recommended<br> | |||
|- | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Cardiac imaging : ([[ACC AHA guidelines classification scheme|Class III, Level of Evidence B]])''' | |||
|- | |||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |||
❑ Routine [[cardiac]] imaging is not recommended in [[patients]] with asymptomatic [[sinus bradycardia]] or [[first-degree atrioventricular block]] and no clinical evidence of [[structural heart disease]]<br> | |||
|} | |||
<span style="font-size:85%">'''Abbreviations:''' | |||
'''PPM:''' [[Permanent pacemaker]]; | |||
'''LBBB:''' [[Left bundle branch block]] | |||
[[ | </span> | ||
<br> | |||
== | {| | ||
! colspan="2" style="background: PapayaWhip;" align="center" + |The above table adopted from 2018 AHA/ACC/HRS Guideline<ref name="KusumotoSchoenfeld2019">{{cite journal|last1=Kusumoto|first1=Fred M.|last2=Schoenfeld|first2=Mark H.|last3=Barrett|first3=Coletta|last4=Edgerton|first4=James R.|last5=Ellenbogen|first5=Kenneth A.|last6=Gold|first6=Michael R.|last7=Goldschlager|first7=Nora F.|last8=Hamilton|first8=Robert M.|last9=Joglar|first9=José A.|last10=Kim|first10=Robert J.|last11=Lee|first11=Richard|last12=Marine|first12=Joseph E.|last13=McLeod|first13=Christopher J.|last14=Oken|first14=Keith R.|last15=Patton|first15=Kristen K.|last16=Pellegrini|first16=Cara N.|last17=Selzman|first17=Kimberly A.|last18=Thompson|first18=Annemarie|last19=Varosy|first19=Paul D.|title=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society|journal=Circulation|volume=140|issue=8|year=2019|issn=0009-7322|doi=10.1161/CIR.0000000000000628}}</ref> | |||
|- | |||
|} | |||
==References== | ==References== |
Latest revision as of 07:49, 11 July 2021
Third degree AV block Microchapters | |
Diagnosis | |
---|---|
Treatment | |
Case Studies | |
Third degree AV block echocardiography and ultrasound On the Web | |
American Roentgen Ray Society Images of Third degree AV block echocardiography and ultrasound | |
FDA on Third degree AV block echocardiography and ultrasound | |
CDC on Third degree AV block echocardiography and ultrasound | |
Third degree AV block echocardiography and ultrasound in the news | |
Blogs on Third degree AV block echocardiography and ultrasound | |
Risk calculators and risk factors for Third degree AV block echocardiography and ultrasound | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Soroush Seifirad, M.D.[3]
Overview
Echocardiography is useful for evaluation of underlying structural heart disease in patients presented with bradycardia or conduction abnormality. Common indications for echocardiography in suspicion of cardiac origin of bradycardia or conduction disorder may include syncope, lightheadedness/presyncope, symptoms related to aortic stenosis, hypertrophic cardiomyopathy, heart failure.
Echocardiography
Echocardiography is useful for evaluation of underlying structural heart disease in patients presented with bradycardia or conduction abnormality including cardiomyopathy, valvular heart disease, congenital anomalies, tumors, infections, infiltrative processes, immunologically mediated conditions, and diseases of the great vessels and pericardium.
- Common indications for echocardiography in suspicion of cardiac origin of bradycardia or conduction disorder may include:
Abbreviations:
PPM: Permanent pacemaker;
LBBB: Left bundle branch block
The above table adopted from 2018 AHA/ACC/HRS Guideline[1] |
---|
References
- ↑ Kusumoto, Fred M.; Schoenfeld, Mark H.; Barrett, Coletta; Edgerton, James R.; Ellenbogen, Kenneth A.; Gold, Michael R.; Goldschlager, Nora F.; Hamilton, Robert M.; Joglar, José A.; Kim, Robert J.; Lee, Richard; Marine, Joseph E.; McLeod, Christopher J.; Oken, Keith R.; Patton, Kristen K.; Pellegrini, Cara N.; Selzman, Kimberly A.; Thompson, Annemarie; Varosy, Paul D. (2019). "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". Circulation. 140 (8). doi:10.1161/CIR.0000000000000628. ISSN 0009-7322.